Miguel Andres Meñaca-Puentes

Mr. Miguel Andres Meñaca-Puentes

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 August 2025 in Nutrients
Verified
Journal Article
Open access
PDF file
CGCarlos Naranjo Galvis
Carlos Naranjo Galvis
DTDiana Trejos-Gallego
Diana Trejos-Gallego
CCCristina Correa-Salazar
Cristina Correa-Salazar
JTJessica Triviño-Valencia
Jessica Triviño-Valencia
MBMarysol Valencia Buitrago
Marysol Valencia Buitrago
LSLuisa Matilde Salamanca-Duque
Luisa Matilde Salamanca-Duque
Background/Objectives: Autism spectrum disorder (ASD) is a neurodevelopmental condition associated with behavioral and cognitive impairments. Increasing evidence also links ASD with systemic immune dysregulation, including abnormal cytokine profiles and chronic low-grade inflammation. Emerging evidence suggests that targeted dietary strategies and probiotic supplementation may modulate immune responses and gut–brain interactions in patients with ASD. This study aimed to evaluate the immunomodulatory effects of a structured anti-inflammatory diet (NeuroGutPlus) compared to multi-strain probiotics in children with ASD. NeuroGutPlus is a nutritionally complete anti-inflammatory dietary protocol that targets gut integrity, inflammation, and mitochondrial function. It includes a diet low in gluten, FODMAPs, casein, and artificial additives, and a high intake of omega-3 fatty acids, polyphenols, and fermentable fibers. Methods: A total of 30 children with ASD and 12 neurotypical controls were enrolled in a 12-week randomized controlled nutritional trial. Participants received either a NeuroGutPlus anti-inflammatory diet, probiotic supplementation (16 strains of Lactobacillus and Bifidobacterium), or no intervention. Plasma levels of 20 cytokines and chemokines were measured pre- and post-intervention using multiplex Luminex immunoassays. Principal component analysis (PCA) was used to explore shifts in the immune profile. Results: Patients treated with the NeuroGutPlus diet significantly reduced IFN-γ levels (p = 0.0090) and showed a stabilizing effect on immune profiles, as evidenced by PCA clustering. Probiotic supplementation led to a significant increase in IL-8 (+66.6 pg/mL; p = 0.0350) and MIP-1β (+74.5 pg/mL; p = 0.0100), along with a decrease in IFN-γ (p = 0.0070), suggesting reconfiguration of innate immune responses. Eight out of eleven biomarkers showed significant post-intervention differences between groups, indicating distinct immunological effects. Conclusions: This study provides evidence that anti-inflammatory diets exert broader and more consistent immunoregulatory effects than probiotics alone in children with ASD. These findings support the inclusion of precision dietary strategies as non-pharmacological interventions to mitigate immune-related dysfunction in patients with ASD.

1 January 2026 in Retos
Verified
Journal Article
Open access
PDF file
LSLuisa Matilde Salamanca-Duque
Luisa Matilde Salamanca-Duque
DGDiana María Trejos Gallego
Diana María Trejos Gallego
JVJessica Triviño Valencia
Jessica Triviño Valencia
MBMarysol Valencia Buitrago
Marysol Valencia Buitrago
MMMiguel Andres Meñaca-Puentes
Miguel Andres Meñaca-Puentes
CGCarlos Naranjo Galvis
Carlos Naranjo Galvis
Introduction: Autism Spectrum Disorder (ASD) is characterized by multiple difficulties in psychomotor development that affect the performance of daily activities and social participation. Several studies have suggested that diet and the balance of the gut microbiota can positively influence the neurodevelopment and functioning characteristics of people with ASD. Objetive: This study explores the effect of an anti-inflammatory diet on psychomotor profiles of children with ASD. Methodology: A quasi-experimental study was conducted with 18 children diagnosed with ASD: 9 in the experimental group and 9 in the control group, and 12 neurotypical children: 6 in the experimental group and 6 in the control group. Patients were evaluated before and after a 12-week anti-inflammatory nutritional intervention. Sociodemographic and clinical characteristics, nutritional status, muscle tone, balance, laterality, spatiotemporal structuring, body notion, global praxia, fine praxia, and psychomotor profile were evaluated. Results: There were significant improvements (p0.8), indicating substantial changes owing to the intervention. Discussion: These findings support the integration of nutritional interventions into interdisciplinary therapeutic programs in clinical and educational contexts. However, further robust studies are required to confirm this. Conclusions: Implementation of an anti-inflammatory diet can improve the psychomotor profile of children with ASD.

26 December 2025 in Medical Sciences
Verified
Journal Article
Open access
PDF file
LRLuisa Fernanda Méndez Ramírez
Luisa Fernanda Méndez Ramírez
MMMiguel Andres Meñaca-Puentes
Miguel Andres Meñaca-Puentes
LSLuisa Matilde Salamanca-Duque
Luisa Matilde Salamanca-Duque
MBMarysol Valencia Buitrago
Marysol Valencia Buitrago
ARAndrés Felipe Ruiz-Pulecio
Andrés Felipe Ruiz-Pulecio
CGCarlos Naranjo Galvis
Carlos Naranjo Galvis
Background/Objective: Neuroimmune and metabolic dysregulation have been increasingly implicated in the cognitive heterogeneity of autism spectrum disorder (ASD). However, it remains unclear whether anti-inflammatory diets engage distinct biological and cognitive pathways in autistic and neurotypical children. This study examined whether a 12-week anti-inflammatory dietary protocol produces group-specific neuroimmune–metabolic signatures and cognitive responses in autistic children, neurotypical children receiving the same diet, and untreated neurotypical controls. Methods: Twenty-two children (11 with ASD, six a on neurotypical diet [NT-diet], and five neurotypical controls [NT-control]) completed pre–post assessments of plasma IFN-γ, CXCL1, RANTES (CCL5), trimethylamine-N-oxide (TMAO), and an extensive ENI-2/WISC-IV neuropsychological battery. Linear mixed-effects models were used to test the Time × Group effects on biomarkers and cognitive domains, adjusting for age, sex, and baseline TMAO. Bayesian estimation quantified individual changes (posterior means, 95% credible intervals, and posterior probabilities). Immune–cognitive coupling was explored using Δ–Δ correlation matrices, network metrics (node strength, degree centrality), exploratory mediation models, and responder (≥0.5 SD domain improvement) versus non-responder analyses. Results: In ASD, the diet induced robust reductions in IFN-γ, RANTES, CXCL1, and TMAO, with decisive Bayesian evidence for IFN-γ and RANTES suppression (posterior P(δ < 0) > 0.99). These shifts were selectively associated with gains in verbal learning, semantic fluency, verbal reasoning, attention, and visuoconstructive abilities, whereas working memory and executive flexibility changes were heterogeneous, revealing executive vulnerability in individuals with smaller TMAO reductions. NT-diet children showed modest but consistent improvements in visuospatial processing, attention, and processing speed, with minimal biomarker changes; NT controls remained biologically and cognitively stable. Network analyses in ASD revealed a dense chemokine-anchored architecture with CXCL1 and RANTES as central hubs linking biomarker reductions to improvements in fluency, memory, attention, and executive flexibility. ΔTMAO predicted changes in executive flexibility only in ASD (explaining >50% of the variance), functioning as a metabolic node of executive susceptibility. Responders displayed larger coordinated decreases in all biomarkers and broader cognitive gains compared to non-responders. Conclusions: A structured anti-inflammatory diet elicits an ASD-specific, coordinated neuroimmune–metabolic response in which suppression of CXCL1 and RANTES and modulation of TMAO are tightly coupled with selective improvements in verbal, attentional, and executive domains. Neurotypical children exhibit modest metabolism-linked cognitive benefits and minimal immune modulation. These findings support a precision-nutrition framework in ASD, emphasizing baseline immunometabolic profiling and network-level biomarkers (CXCL1, RANTES, TMAO) to stratify responders and design combinatorial interventions targeting neuroimmune–metabolic pathways.